$AORT · Artivion, Inc. Congress Trades

Representative Gilbert Cisneros executed a large portfolio rebalancing in August 2026, involving 70+ transactions across stocks and municipal bonds held in the 150 Main Street Trust. Notable activity includes purchases of Microsoft ($15,001-$50,000), Eaton Corporation ($15,001-$50,000), Globus Medical ($15,001-$50,000), and Moog Inc. ($15,001-$50,000), alongside sales of multiple Lamar Advertising positions totaling $60,001-$200,000 combined, sales of Dollar Tree ($15,001-$50,000), Nike ($15,001-$50,000), and Sterling Infrastructure ($15,001-$50,000), plus a significant purchase of New Jersey Health Care Facilities Financing Authority Revenue Bonds ($250,001-$500,000).

Hon. Gilbert Cisneros executed 89 transactions in July 2026, with a mix of purchases and sales across diverse sectors including technology, healthcare, financials, and consumer goods. The largest single transaction was a sale of $100,001-$250,000 in Alibaba Group Holdings (BABA), while other significant positions included purchases in Microsoft (MSFT), Mesabi Trust (MSB), Sprouts Farmers Market (SFM), Fabrinet (FN), Crinetics Pharmaceuticals (CRNX), and Alkermes (ALKS) in the $15,001-$50,000 range.

Hon. Gilbert Cisneros made extensive portfolio trades in October 2025, primarily purchasing a diversified array of stocks (including AAPL, MSFT, NVDA, META, GOOGL, AMZN, and many others in the $1,001-$15,000 range each) while also selling several bond positions and select equities. Notable large transactions included the sale of California State Public Works Board Lease Revenue Bonds ($250,001-$500,000), purchase of Milwaukee GO Promissory Notes and Missouri Health and Educational Facilities Authority Revenue Bonds (each $250,001-$500,000), and multiple sales of GoDaddy stock totaling approximately $15,001-$50,000.

Rep. Josh Gottheimer (NJ-05) executed a high-volume portfolio rebalancing in July 2023, trading approximately 60+ stocks through a Morgan Stanley Select UMA account with mostly mixed buys and sells of large-cap tech, pharma, and international stocks, each in the $1,001-$15,000 range.